600664.SH
Harbin Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 5.40
+1.89%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 23.13x
- P/E 2027E
- 19.82x
- P/E 2028E
- 17.34x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 37.61x
- PEG TTM
- —
- Price / book
- 2.16x
- Price / sales
- 0.88x
- Price / cash flow
- 19.46x
Enterprise value
- Enterprise value
- CNY 12.7B
- EV / sales
- 0.79x
- EV / EBITDA
- 15.43x
- EV / EBIT
- 24.23x
- Market cap
- CNY 13.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026